Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Express Scripts
Johnson and Johnson
Baxter

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Suppliers and packages for tradename: LAMICTAL ODT

See Plans and Pricing

« Back to Dashboard

LAMICTAL ODT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Glaxosmithkline Llc LAMICTAL ODT lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 NDA GlaxoSmithKline LLC 0173-0772-02 1 DOSE PACK in 1 CARTON (0173-0772-02) > 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK
Glaxosmithkline Llc LAMICTAL ODT lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 NDA GlaxoSmithKline LLC 0173-0774-02 1 DOSE PACK in 1 CARTON (0173-0774-02) > 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK
Glaxosmithkline Llc LAMICTAL ODT lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 NDA GlaxoSmithKline LLC 0173-0776-02 1 DOSE PACK in 1 CARTON (0173-0776-02) > 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK
Glaxosmithkline Llc LAMICTAL ODT lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 NDA GlaxoSmithKline LLC 0173-0777-02 1 DOSE PACK in 1 CARTON (0173-0777-02) > 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK
Glaxosmithkline Llc LAMICTAL ODT lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 NDA GlaxoSmithKline LLC 0173-0778-00 1 BLISTER PACK in 1 PACKAGE, COMBINATION (0173-0778-00) > 1 KIT in 1 BLISTER PACK
Glaxosmithkline Llc LAMICTAL ODT lamotrigine TABLET, ORALLY DISINTEGRATING;ORAL 022251 NDA GlaxoSmithKline LLC 0173-0779-00 1 BLISTER PACK in 1 PACKAGE, COMBINATION (0173-0779-00) > 1 KIT in 1 BLISTER PACK
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews